Results 211 to 220 of about 85,025 (319)

Effect of SstI Polymorphism of the Apolipoprotein CIII Gene and Environmental Factors on Risks of Hypertriglyceridemia in Taiwan Aborigines

, 2006
Meng‐Chuan Huang, Tsu‐Nai Wang, Yiling Liu, Te-Hsiung Pa, Hung‐Pin Tu, Yi‐Chia Huang, Wen‐Tsan Chang, Ying‐Chin Ko   +7 more
openalex   +2 more sources

Effect of Calafate (Berberis microphylla) Intake on Plasma Atherogenic Indices in Rats With High‐Sucrose Diet–Induced Obesity

Journal of Nutrition and Metabolism, Volume 2026, Issue 1, 2026.
Cardiovascular diseases (CVDs) are multifactorial conditions strongly linked to elevated obesity rates and sedentary lifestyle; among the contributing mechanisms, alterations in lipid metabolism—particularly dyslipidemia—play a central role in their pathogenesis.
Carla Guzmán-Pincheira, Gabriel Araujo-Silva, Raul Sánchez-Gutiérrez, Roxana Valdés-Ramos   +3 more
wiley   +1 more source

Olezarsen: A Next-Generation Antisense Therapy for Hypertriglyceridemia and Familial Chylomicronemia Syndrome. [PDF]

Cureus
Joshy J, Javed A, Kumar Singh M, Singh BP, Kumar R, Hussain S.   +5 more
europepmc   +1 more source

Genetic Variants Associated with Gestational Hypertriglyceridemia and Pancreatitis

, 2015
Saili Xie, Tanzhou Chen, Xielin Huang, Chao Chen, Rong Jin, Zhiming Huang, Mengtao Zhou   +6 more
openalex   +2 more sources

Discovery of Triacylglycerol‐Binding Proteins in Cereus jamacaru DC. Through Integrative In Silico Methods

Journal of Chemistry, Volume 2026, Issue 1, 2026.
The Caatinga biome in Brazil harbors unique bioactive plants, such as Cereus jamacaru DC. Historically, it has been used in traditional medicine for treating kidney issues, diabetes, and cardiovascular conditions; however, these ethnobotanical reports do not constitute evidence of clinical efficacy. Here, we integrate transcriptomics, molecular docking,
M. I. O. Cardoso, J. Oliveira, V. Bassaneze, D. T. Amaral, Sohini Basu Roy   +4 more
wiley   +1 more source

Analysis of Intravenous Insulin Dosing Requirements for Treatment of Severe Hypertriglyceridemia

, 2022
Brittany White, Breanna L. Carter, J. Lacie Bradford   +2 more
openalex   +2 more sources

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS‐1): A multicenter, randomized, double‐blind, placebo‐controlled phase 3 trial

CA: A Cancer Journal for Clinicians, Volume 76, Issue 1, January/February 2026.
Abstract Although poly(adenosine diphosphate‐ribose) polymerase inhibitors (PARPis) and bevacizumab were approved as first‐line maintenance for advanced ovarian cancer (OC), evidence comparing this combination with PARPi monotherapy, especially in BRCA‐mutated/homologous recombination‐deficient (HRD) patients, is lacking.
Lingying Wu, Jing Wang, Qingshui Li, Danbo Wang, Cuiying Zhang, Junying Tang, Guonan Zhang, Min Hao, Desheng Yao, Qinglei Gao, Youzhong Zhang, Ruifang An, Rutie Yin, Li Wang, Bairong Xia, Qi Zhou, Hongying Yang, Jianqing Zhu, Kui Jiang, Zhengzheng Chen, Qiang Wu, Wei Duan, Yi Huang, Hui Zhang, Shuqing Wei, Guiling Li, Yuanguang Meng, Ke Wang, Xinfeng Yang, Xianghua Huang, Lingya Pan, Jinjin Yu, Ge Lou, Yu Zhang, Huaijun Zhou, Xiaoqing Guo, Hong Yang, Xiaodong Cheng, Xiumin Li, Wuliang Wang, Hongqin Zhao, Yunxia Li, Yingjie Yang, An Lin, Wenjun Cheng, Lihong Chen, Xiaoying Xie, Wen Di, Yuanjing Hu, Mo Chen, Hongwu Wen, Liping Cai, Xiaohua Wu, Zhongqiu Lin, Quanren Wang, Xinfeng Yang, Ning Li   +56 more
wiley   +1 more source

Case Report: Generalized lipodystrophy following immune-checkpoint inhibitor therapy. [PDF]

Front Endocrinol (Lausanne)
Lee AH, Hui R, Gunton JE.
europepmc   +1 more source

Plasmapheresis as a Life-Saving Measure for Severe Hypertriglyceridemia-Induced Acute Pancreatitis. [PDF]

Cureus
Neduvancheri F, Sumi FS, Shaheer R, Shereef M M, Sivadas S, Kallarikkandi T, Narayanan R.   +6 more
europepmc   +1 more source

Successful Use of Glucagon-Like Peptide-1 Receptor Agonist in a Patient With Recurrent Hypertriglyceridemia-Induced Pancreatitis. [PDF]

ACG Case Rep J
Guralwar C, Mitsuhashi S, Ashkar M, Chedid VG.   +3 more
europepmc   +1 more source